Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 2 (2005), Issue 3 (March)

1. Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha.
   Mol Cell Endocrinol, 232(1): 1-8. [Abstract] [Full-text]
2. In vitro chronic hepatic disease characterization with a multiparametric ultrasonic approach.
   Ultrasonics, 43(5): 305-13. [Abstract] [Full-text]
3. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
   Aliment Pharmacol Ther, 21(5): 519-24. [Abstract] [Full-text]
4. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
   Proc Natl Acad Sci U S A, 102(9): 3389-94. [Abstract] [Full-text]
5. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
   Am J Gastroenterol, 100(3): 636-42. [Abstract] [Full-text]
6. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
   Am J Gastroenterol, 100(3): 631-5. [Abstract] [Full-text]
7. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.
   Am J Gastroenterol, 100(3): 624-30. [Abstract] [Full-text]
8. Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis.
   Fertil Steril, 83(3): 761-3. [Abstract] [Full-text]
9. Liver resection for hepatocellular carcinoma in patients with cirrhosis.
   Br J Surg, 92(3): 348-55. [Abstract] [Full-text]
10. A scoring system for the assessment of the risk of mortality after partial hepatectomy in patients with chronic liver dysfunction.
    J Hepatobiliary Pancreat Surg, 12(1): 44-8. [Abstract] [Full-text]
11. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.
    Gut, 54(4): 528-32. [Abstract] [Full-text]
12. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
    Gut, 54(4): 522-7. [Abstract] [Full-text]
13. Hepatoprotective and antioxidant effects of Morus bombycis Koidzumi on CCl4-induced liver damage.
    Biochem Biophys Res Commun, 329(3): 991-5. [Abstract] [Full-text]
14. Pharmacokinetics of pitavastatin in subjects with Child-Pugh A and B cirrhosis.
    Br J Clin Pharmacol, 59(3): 291-7. [Abstract] [Full-text]
15. Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice.
    Cytokine, 29(5): 236-44. [Abstract] [Full-text]
16. Adhesion molecules as a prognostic marker of liver cirrhosis.
    Scand J Gastroenterol, 40(2): 217-24. [Abstract] [Full-text]
17. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
    J Hepatol, 42(4): 573-7. [Abstract] [Full-text]
18. Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.
    J Hepatol, 42(4): 548-56. [Abstract] [Full-text]
19. Effect of alcohol on viral hepatitis and other forms of liver dysfunction.
    Clin Liver Dis, 9(1): 83-101. [Abstract] [Full-text]
20. Morphology of alcoholic liver disease.
    Clin Liver Dis, 9(1): 37-53. [Abstract] [Full-text]
21. Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis.
    Life Sci, 76(21): 2497-512. [Abstract] [Full-text]
22. Detection of early central circulatory transits in patients with cirrhosis by gamma variate fit of indicator dilution profiles.
    Am J Physiol Gastrointest Liver Physiol, 288(4): G677-84. [Abstract] [Full-text]
23. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers.
    Am J Physiol Gastrointest Liver Physiol, 288(4): G763-70. [Abstract] [Full-text]
24. Lack of therapeutic improvement of liver fibrosis in rats by dexamethasone in spite of ascites amelioration.
    Chem Biol Interact, 152(1): 37-47. [Abstract] [Full-text]
25. Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices.
    Digestion, 70(4): 233-9. [Abstract] [Full-text]
26. Juvenile hepatocellular carcinoma with congestive liver cirrhosis.
    J Gastroenterol, 40(2): 204-8. [Abstract] [Full-text]
27. Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts.
    J Gastroenterol, 40(2): 164-70. [Abstract] [Full-text]
28. Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis.
    J Gastroenterol, 40(2): 157-63. [Abstract] [Full-text]
29. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats.
    Life Sci, 76(22): 2593-606. [Abstract] [Full-text]
30. Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis.
    Aliment Pharmacol Ther, 21(6): 701-7. [Abstract] [Full-text]
31. The reverse target sign in liver disease: a potential ultrasound feature in cirrhotic liver nodules characterization.
    Br J Radiol, 78(928): 355-7. [Abstract] [Full-text]
32. Modified saphenous-peritoneal shunt in refractory ascites: new technique.
    ANZ J Surg, 75(3): 128-31. [Abstract] [Full-text]
33. Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.
    J Biol Chem, 280(12): 11329-39. [Abstract] [Full-text]
34. The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites.
    Liver Int, 25(2): 429-37. [Abstract] [Full-text]
35. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
    Liver Int, 25(2): 403-9. [Abstract] [Full-text]
36. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
    Liver Int, 25(2): 357-66. [Abstract] [Full-text]
37. Intrahepatic circulatory time analysis of an ultrasound contrast agent in liver cirrhosis.
    Liver Int, 25(2): 337-42. [Abstract] [Full-text]
38. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis.
    Liver Int, 25(2): 331-6. [Abstract] [Full-text]
39. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
    Liver Int, 25(2): 317-24. [Abstract] [Full-text]
40. Osteoprotegerin and RANKL in alcoholic liver cirrhosis.
    Liver Int, 25(2): 305-10. [Abstract] [Full-text]
41. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.
    Liver Int, 25(2): 294-304. [Abstract] [Full-text]
42. Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver.
    Liver Int, 25(2): 288-93. [Abstract] [Full-text]
43. Physical hemodynamic interaction between portal venous and hepatic arterial blood flow in humans.
    Liver Int, 25(2): 282-7. [Abstract] [Full-text]
44. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Liver Int, 25(2): 226-35. [Abstract] [Full-text]
45. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Liver Int, 25(2): 220-5. [Abstract] [Full-text]
46. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis.
    Braz J Med Biol Res, 38(2): 271-6. [Abstract] [Full-text]
47. Large liver cell dysplasia in hepatitis B virus x transgenic mouse liver and human chronic hepatitis B virus-infected liver.
    Intervirology, 48(1): 16-22. [Abstract] [Full-text]
48. Could the high level of cirrhosis in central and eastern Europe be due partly to the quality of alcohol consumed? An exploratory investigation.
    Addiction, 100(4): 536-42. [Abstract] [Full-text]
49. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
    Am J Gastroenterol, 100(4): 837-41. [Abstract] [Full-text]
50. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
    J Intern Med, 257(4): 358-66. [Abstract] [Full-text]
51. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Br J Dermatol, 152(3): 451-8. [Abstract] [Full-text]
52. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.
    Liver Transpl, 11(4): 456-62. [Abstract] [Full-text]
53. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.
    J Antimicrob Chemother, 55(4): 417-9. [Abstract] [Full-text]
54. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
    J Med Virol, 76(1): 61-8. [Abstract] [Full-text]
55. Different tumor necrosis factor-alpha-associated leptin expression in rats with dimethylnitrosamine and bile duct ligation-induced liver cirrhosis.
    Metabolism, 54(4): 445-52. [Abstract] [Full-text]
56. Monounsaturated and omega-3 but not omega-6 polyunsaturated fatty acids improve hepatic fibrosis in hypercholesterolemic rabbits.
    Nutrition, 21(3): 363-71. [Abstract] [Full-text]
57. A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes.
    World J Surg, 29(2): 124-30. [Abstract] [Full-text]

© 2004-2010 Liver Cirrhosis Research Today. All Rights Reserved.